HighTower Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-477
Closed -$45K 2350
2017
Q1
$45K Hold
477
﹤0.01% 1928
2016
Q4
$35K Sell
477
-3
-0.6% -$229 ﹤0.01% 1840
2016
Q3
$53K Hold
480
﹤0.01% 1783
2016
Q2
$50K Buy
480
+4
+0.8% +$286 ﹤0.01% 1643
2016
Q1
$36K Hold
476
﹤0.01% 1973
2015
Q4
$38K Hold
476
﹤0.01% 1909
2015
Q3
$320K Hold
476
﹤0.01% 1424
2015
Q2
$317K Hold
476
0.01% 1172
2015
Q1
$319K Hold
476
﹤0.01% 1214
2014
Q4
$250K Buy
476
+29
+6% +$14.5K ﹤0.01% 1307
2014
Q3
$266K Buy
447
+36
+9% +$24.9K ﹤0.01% 1258
2014
Q2
$269K Hold
411
﹤0.01% 1292
2014
Q1
$323K Hold
411
0.01% 1139
2013
Q4
$317K Hold
411
0.01% 1142
2013
Q3
$315K Hold
411
0.01% 1014
2013
Q2
$357K Buy
+411
New +$348K 0.01% 924

Other funds holding MTEM

HighTower Advisors's MTEM Position: Q2 2017 in Review

HighTower Advisors sold out of Molecular Templates, Inc. (MTEM) in Q2 2017, closing a stake of 477 shares — an estimated $45K sold.

HighTower Advisors first reported a position in MTEM in Q2 2013 and held it in 16 quarters. The position peaked at $357K in Q2 2013. 37 funds tracked by Wall St. Rank hold MTEM as of Q2 2017.

  • HighTower Advisors reported no remaining Molecular Templates, Inc. position as of Q2 2017 after selling out during the quarter.
  • HighTower Advisors sold 477 Molecular Templates, Inc. shares in Q2 2017, an estimated $45K.
  • HighTower Advisors first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 16 quarters.
  • HighTower Advisors's Molecular Templates, Inc. position peaked at $357K in Q2 2013.
  • 37 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2017.

Based on HighTower Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.